Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G MOERTEL

Showing results (101-110 of 147) with videos related to

Pageof 15
Sort By:
Cancer|May 1, 1989
Patterns of occult bleeding in asymptomatic colorectal cancerD A Ahlquist, D B McGill, J L Fleming, et al.
Cancer Treatment Reports|September 1, 1983
Pharmacokinetics of mitomycin C in patients receiving the drug alone or in combinationG A van Hazel, M Scott, J Rubin, et al.
Surgery, Gynecology & Obstetrics|January 11, 1992
Patterns of recurrence after curative resection of carcinoma of the colon and rectumS Galandiuk, H S Wieand, C G Moertel, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1982
A prospective controlled evaluation of combined pelvic radiotherapy and methanol extraction residue of BCG (MER) for locally unresectable or recurrent rectal carcinomaM J O'Connell, D S Childs, C G Moertel, et al.
Cancer|April 1, 1990
A phase II study of the combination of etoposide and cisplatin in the therapy of advanced gastric cancerT E Elliott, C G Moertel, H S Wieand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment GroupC G Moertel, L L Gunderson, J A Mailliard, et al.
Annals of Internal Medicine|July 4, 1998
Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology GroupR M Goldberg, T R Fleming, C M Tangen, et al.
Cancer Research|July 1, 1990
Phase I and clinical pharmacological evaluation of pirozantrone hydrochloride (oxantrazole)M M Ames, C L Loprinzi, J M Collins, et al.
Cancer|July 1, 1977
A phase II study of triazinate (NSC 139105) in advanced colorectal carcinomaR H McCreary, C G Moertel, A J Schutt, et al.
Annals of Internal Medicine|December 1, 1979
Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placeboS Frytak, C G Moertel, J R O'Fallon, et al.
Pageof 15

Showing results (101-110 of 147) with videos related to

Sort By:
Pageof 15
Cancer|May 1, 1989
Patterns of occult bleeding in asymptomatic colorectal cancerD A Ahlquist, D B McGill, J L Fleming, et al.
Cancer Treatment Reports|September 1, 1983
Pharmacokinetics of mitomycin C in patients receiving the drug alone or in combinationG A van Hazel, M Scott, J Rubin, et al.
Surgery, Gynecology & Obstetrics|January 11, 1992
Patterns of recurrence after curative resection of carcinoma of the colon and rectumS Galandiuk, H S Wieand, C G Moertel, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1982
A prospective controlled evaluation of combined pelvic radiotherapy and methanol extraction residue of BCG (MER) for locally unresectable or recurrent rectal carcinomaM J O'Connell, D S Childs, C G Moertel, et al.
Cancer|April 1, 1990
A phase II study of the combination of etoposide and cisplatin in the therapy of advanced gastric cancerT E Elliott, C G Moertel, H S Wieand, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment GroupC G Moertel, L L Gunderson, J A Mailliard, et al.
Annals of Internal Medicine|July 4, 1998
Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology GroupR M Goldberg, T R Fleming, C M Tangen, et al.
Cancer Research|July 1, 1990
Phase I and clinical pharmacological evaluation of pirozantrone hydrochloride (oxantrazole)M M Ames, C L Loprinzi, J M Collins, et al.
Cancer|July 1, 1977
A phase II study of triazinate (NSC 139105) in advanced colorectal carcinomaR H McCreary, C G Moertel, A J Schutt, et al.
Annals of Internal Medicine|December 1, 1979
Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placeboS Frytak, C G Moertel, J R O'Fallon, et al.
Pageof 15